News

New pill is effective against gonorrhea as antibiotic resistance surges: Study
A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...
GSK (LSE:GSK) Sees 6% Share Price Decline Over The Last Quarter
GSK (LSE:GSK) recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and ...
Endocrinology Advisor6d
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
New antibiotic could treat drug-resistant gonorrhea: Study
A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...
A growing number of UTIs are resistant to antibiotics. Experts say it's the 'canary in the coal mine' for a bigger problem.
Antibiotic resistance is a major threat to human health. But experts say there are steps people can take to reduce the risk.
A new type of antibiotic is effective against gonorrhea as drug resistance surges
A pill developed by GSK was found to be safe and effective in treating gonorrhea. It could be the first new type of ...
pharmaphorum2d
GSK ends decades-long hiatus in oral antibiotics for UTIs
"The approval of Blujepa is a crucial milestone with uUTIs among the most common infections in women," said GSK's chief scientific offer Tony Wood, pointing out that around 16 million women in the ...
KFF Health News18h
Ransomware Attack Hits Kidney Care Provider DaVita
Parts of DaVita's network were locked down by the attack, and the company has not yet provided a timeline for recovery. DaVita works with over 700 U.S. hospitals providing kidney dialysis. In pharma ...